Market Herald logo

Subscribe

Be the first with the news that moves the market

Creso Pharma Limited announced an AUD$5.35 million investment from various investors. Investments came from a series of loans, payable at 15 per cent, per annum interest.

Creso Pharma Limited cultivate and produce cannabis pharmaceutical treatments. Funds will increase sales of Creso’s human and animal products in Europe and Canada.

Funds will also be used to increase Cannabis cultivation, repay debts and provide working capital. Capital raising was managed by EverBlu Capital Limited and will receive a six percent, or $300,000 fee.

The company plans to seek shareholder approval to repay the principal of loans through 107 convertible notes. The planned convertible notes will have a face value of $50,000.

Investors also have the option to convert the notes into company shares at the conversion price of $0.50.

“We are pleased to announce this successful capital raising which was strongly supported by strategic and sophisticated investors. The Company wishes to take this opportunity to thank investors for their ongoing support,” Creso CEO Miri Halperin said.

Creso currently operates and owns a 2,200 square metre cannabis facility in Canada. Only until recently has Creso received a cultivation licence for the facility. The company expects the facility to help generate this year’s quarterly revenue.

Creso currently has two human and two animal cannabis health products on the market in Europe. A further four new products are ready for launch.

Please see the announcement attached

CPH by the numbers
More From The Market Herald
Australia and New Zealand Banking Group (ASX:ANZ) - New Zealand CEO, Antonia Watson

" ANZ Bank (ASX:ANZ) cashes in on UDC Finance asset sale

ANZ Bank (ASX:ANZ) has sold New Zealand asset finance company UDC Finance to Shinsei Bank for…

" AMP (ASX:AMP) braces for $4b hit to FUM after Woolworths ends contract

AMP (ASX:AMP) expects a $4 billion hit to its funds under management following the termination of…

" AMP (ASX:AMP) divests its interest in Resolution Life Australasia for $524m

AMP Limited (ASX:AMP) has divested its equity interest in Resolution Life Australia (RLA) to Resolution Life…
AMP (ASX:AMP) - Chief Executive Officer, Alexis George

" AMP (ASX:AMP) flags 2021 full-year loss as demerger looms

AMP (ASX:AMP) has announced a slip in revenue and steep full-year loss for its 2021 financial…